Gene · 2822
Papers4,132
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,132
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lysophospholipids: A Potential Drug Candidates for Neurodegenerative Disorders. | Biomedicines | 2022 | 36551882 | PubTator, text mining | PubMed |
| Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells. | Cancers (Basel) | 2022 | 36551699 | PubTator, text mining | PubMed |
| Phytocyanin-encoding genes confer enhanced ozone tolerance in Arabidopsis thaliana. | Sci Rep | 2022 | 36550187 | PubTator, text mining | PubMed |
| Development of a thiostrepton-free system for stable production of PLD in Streptomyces lividans SBT5. | Microb Cell Fact | 2022 | 36529749 | PubTator, text mining | PubMed |
| Membrane protein trafficking in the anti-tumor immune response: work of endosomal-lysosomal system. | Cancer Cell Int | 2022 | 36528587 | PubTator, text mining | PubMed |
| Evaluation of the effects of Loxosceles intermedia's venom in zebrafish. | Toxicol Rep | 2022 | 36518468 | PubTator, text mining | PubMed |
| Mechanistic insight into female predominance in Alzheimer's disease based on aberrant protein S-nitrosylation of C3. | Sci Adv | 2022 | 36516243 | PubTator, text mining | PubMed |
| Dissecting peripheral protein-membrane interfaces. | PLoS Comput Biol | 2022 | 36516231 | PubTator, text mining | PubMed |
| GRP78 Activity Moderation as a Therapeutic Treatment against Obesity. | Int J Environ Res Public Health | 2022 | 36498048 | PubTator, text mining | PubMed |
| Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in Alzheimer's disease. | Front Aging Neurosci | 2022 | 36466600 | PubTator, text mining | PubMed |
| Chemoenzymatic synthesis of sulfur-linked sugar polymers as heparanase inhibitors. | Nat Commun | 2022 | 36460670 | PubTator, text mining | PubMed |
| Arg/Lys-containing IDRs are cryptic binding domains for ATP and nucleic acids that interplay to modulate LLPS. | Commun Biol | 2022 | 36450893 | PubTator, text mining | PubMed |
| High Intensity Acute Aerobic Exercise Elicits Alterations in Circulating and Skeletal Muscle Tissue Expression of Neuroprotective Exerkines. | Brain Plast | 2022 | 36448040 | PubTator, text mining | PubMed |
A lipidomics platform to analyze the fatty acid compositions of non-polar and polar lipid molecular species from plant tissues: Examples from developing seeds and seedlings of pennycress (Thlaspi arvense). | Front Plant Sci | 2022 | 36438089 | PubTator, text mining | PubMed |
| Adaptive sequence divergence forged new neurodevelopmental enhancers in humans. | Cell | 2022 | 36423581 | PubTator, text mining | PubMed |
| Construction of a multiple-class classifier based on mRNAs and lncRNA FAM66A and PSORS1C3 for predicting distant metastasis in lung adenocarcinoma. | Ann Transl Med | 2022 | 36388820 | PubTator, text mining | PubMed |
| Breast cancer liver metastasis: Pathogenesis and clinical implications. | Front Oncol | 2022 | 36387238 | PubTator, text mining | PubMed |
| The oldest unvaccinated Covid-19 survivors in South America. | Immun Ageing | 2022 | 36384671 | PubTator, text mining | PubMed |
| Prevalence and global estimates of unsafe listening practices in adolescents and young adults: a systematic review and meta-analysis. | BMJ Glob Health | 2022 | 36379592 | PubTator, text mining | PubMed |
| Immunoprophylactic properties of the Corynebacterium pseudotuberculosis-derived MBP:PLD:CP40 fusion protein. | Appl Microbiol Biotechnol | 2022 | 36374330 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2822/papers?page=26